Jane Street
REVB icon

Jane Street’s Revelation Biosciences REVB Stock Holding History

Jane Street’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,691
Closed -$21K – 12163
2025
Q3 		$21K Buy
+3,691
New +$35.8K ﹤0.01% 10526
2022
Q2 		– Hold
0
– -$22K – 10667
2022
Q1 		– Hold
0
– – – 9909
2021
Q4 		– Hold
0
– -$581K – 10697
2021
Q3 		– Hold
0
– – – 7003
2021
Q2 		– Hold
0
– – – 6963
2021
Q1 		– Hold
0
– – – 6629

Other funds holding REVB

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Jane Street's REVB Position: Q4 2025 in Review

Jane Street sold out of Revelation Biosciences (REVB) in Q4 2025, closing a stake of 3,691 shares — an estimated $21K sold.

Jane Street first reported a position in REVB in Q3 2025 and held it in 1 quarter. The position peaked at $21K in Q3 2025. 13 funds tracked by Wall St. Rank hold REVB as of Q4 2025.

  • Jane Street reported no remaining Revelation Biosciences position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 3,691 Revelation Biosciences shares in Q4 2025, an estimated $21K.
  • Jane Street first reported a position in Revelation Biosciences in Q3 2025 and held it in 1 quarter.
  • Jane Street's Revelation Biosciences position peaked at $21K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Revelation Biosciences as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.